A detailed history of Victory Capital Management Inc transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 542,380 shares of GRTS stock, worth $16,271. This represents 0.0% of its overall portfolio holdings.

Number of Shares
542,380
Previous 553,150 1.95%
Holding current value
$16,271
Previous $342,000 8.19%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$0.45 - $0.71 $4,846 - $7,646
-10,770 Reduced 1.95%
542,380 $314,000
Q2 2024

Aug 05, 2024

BUY
$0.62 - $2.35 $335,653 - $1.27 Million
541,377 Added 4598.46%
553,150 $342,000
Q1 2024

May 03, 2024

SELL
$1.96 - $2.9 $103 - $153
-53 Reduced 0.45%
11,773 $30,000
Q4 2023

Feb 05, 2024

BUY
$1.28 - $2.85 $15,137 - $33,704
11,826 New
11,826 $24,000
Q4 2020

Feb 01, 2021

SELL
$2.57 - $4.22 $160,239 - $263,117
-62,350 Closed
0 $0
Q3 2020

Nov 09, 2020

SELL
$2.63 - $8.09 $459,508 - $1.41 Million
-174,718 Reduced 73.7%
62,350 $165,000
Q2 2020

Aug 07, 2020

SELL
$5.69 - $8.17 $651,761 - $935,832
-114,545 Reduced 32.58%
237,068 $1.57 Million
Q1 2020

May 04, 2020

SELL
$5.47 - $11.3 $85,982 - $177,624
-15,719 Reduced 4.28%
351,613 $2.05 Million
Q4 2019

Feb 06, 2020

BUY
$7.07 - $11.61 $17,378 - $28,537
2,458 Added 0.67%
367,332 $3.3 Million
Q4 2019

Feb 04, 2020

SELL
$7.07 - $11.61 $161,323 - $264,916
-22,818 Reduced 5.89%
364,874 $3.23 Million
Q3 2019

Nov 12, 2019

BUY
$8.45 - $12.28 $799,893 - $1.16 Million
94,662 Added 32.3%
387,692 $3.35 Million
Q2 2019

Aug 15, 2019

BUY
$9.2 - $15.7 $204,147 - $348,383
22,190 Added 8.19%
293,030 $3.26 Million
Q1 2019

May 03, 2019

BUY
$9.97 - $18.96 $1.96 Million - $3.73 Million
196,650 Added 265.06%
270,840 $3.6 Million
Q4 2018

Feb 05, 2019

SELL
$11.61 - $31.1 $299,654 - $802,691
-25,810 Reduced 25.81%
74,190 $1.15 Million
Q3 2018

Nov 01, 2018

BUY
$14.24 - $14.24 $1.42 Million - $1.42 Million
100,000 New
100,000 $1.42 Million

Others Institutions Holding GRTS

About Gritstone bio, Inc.


  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.